85%Confidence
0Views
FDASource
2026-04-14Date
Summary
Strides Pharma's Class II recall for Children's Ibuprofen due to foreign particles indicates contamination issues, which could lead to consumer distrust and regulatory penalties. This may impact Taro Pharmaceuticals' brand and sales in the pediatric OTC market.
Actionable: Assess other pediatric pain reliever brands for potential substitution effects.
AI Confidence: 85%
Data Points
firmSTRIDES PHARMA INC
classificationClass II
statusOngoing
distributionU.S.A. Nationwide
productChildren's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY
Get Signals Instantly
Premium subscribers receive every signal via Telegram the moment it fires — hours before it appears here.
Subscribe Now